On the basis of results suggesting the involvement of OSM in the early stage of experimental NAFLD/NASH as well as in specimens from human NASH patients, we next analyzed the potential direct pro-fibrogenic role of OSM on myofibroblast-like cells. The gene discussed is OSM; the disease is metabolic dysfunction-associated steatotic liver disease.